Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages

M J Díaz-Guerra1, A Castrillo, P Martín-Sanz

  • 1Instituto de Bioquímica, Facultad de Farmacia, 28040 Madrid, Spain.

Insights

Phosphatidylinositol 3-kinase (PI3-kinase) negatively regulates macrophage activation. Inhibiting PI3-kinase increases nitric oxide production and enhances NF-kappaB activation, suggesting a role in anti-inflammatory cytokine action.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Lipopolysaccharide (LPS) transiently activates phosphatidylinositol 3-kinase (PI3-kinase) in RAW 264.7 macrophages.
  • Macrophage activation involves complex signaling pathways influencing inflammatory responses.

Purpose of the Study:

  • To investigate the role of PI3-kinase in modulating macrophage activation by LPS.
  • To determine PI3-kinase's influence on inducible nitric oxide synthase (iNOS) and NF-kappaB signaling.

Main Methods:

  • RAW 264.7 macrophage cell line stimulation with LPS.
  • Inhibition of PI3-kinase using wortmannin and LY294002.
  • Measurement of iNOS and nitric oxide synthesis.
  • NF-kappaB activation assays and iNOS promoter activity analysis via transfection.

Main Results:

  • PI3-kinase inhibition by wortmannin and LY294002 increased iNOS expression and nitric oxide production.
  • Wortmannin treatment prolonged NF-kappaB activation and enhanced iNOS gene promoter activity.
  • Modulating PI3-kinase catalytic activity affected iNOS promoter responsiveness to LPS and wortmannin.

Conclusions:

  • PI3-kinase acts as a negative regulator in LPS-induced macrophage activation.
  • These findings suggest PI3-kinase is involved in the mechanism of anti-inflammatory cytokines.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...